{"id":"sv-br-1-gm","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The drug is a personalized cancer vaccine composed of dendritic cells derived from the patient's own immune system, which are ex vivo loaded with lysate from the patient's own breast cancer tissue. These antigen-loaded dendritic cells are then reinfused to prime and activate the patient's T cells against breast cancer-specific antigens, generating a targeted anti-tumor immune response.","oneSentence":"SV-BR-1-GM is an autologous breast cancer immunotherapy that uses patient-derived dendritic cells loaded with breast cancer-associated antigens to stimulate anti-tumor immune responses.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:37:04.831Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Breast cancer (Phase 3 development)"}]},"trialDetails":[{"nctId":"NCT03328026","phase":"PHASE1, PHASE2","title":"Combination Study of SV-BR-1-GM With Retifanlimab","status":"COMPLETED","sponsor":"BriaCell Therapeutics Corporation","startDate":"2018-03-16","conditions":"Breast Cancer, Breast Neoplasm, Metastatic Breast Cancer","enrollment":36},{"nctId":"NCT06072612","phase":"PHASE3","title":"Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.","status":"RECRUITING","sponsor":"BriaCell Therapeutics Corporation","startDate":"2023-12-05","conditions":"Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm","enrollment":404},{"nctId":"NCT07199413","phase":"PHASE1","title":"Allogeneic, Antigen-Presenting, GM-CSF-secreting, SV-BR-1-GM Whole Cell-Therapeutic Vaccine and Immunotherapy: A Phase I Pilot Safety and Feasibility Study for Solid Tumor Patients With CNS Metastases","status":"NOT_YET_RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2026-03-01","conditions":"Brain Metastases, Leptomeningeal Metastasis","enrollment":20},{"nctId":"NCT04418219","phase":"PHASE1, PHASE2","title":"Breast Cancer Vaccine in Combination With Pembrolizumab for Treatment of Persistent, Recurrent, or Metastatic Breast Cancer","status":"WITHDRAWN","sponsor":"Thomas Jefferson University","startDate":"2020-12-21","conditions":"Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8","enrollment":""},{"nctId":"NCT06471673","phase":"PHASE1, PHASE2","title":"A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer","status":"RECRUITING","sponsor":"BriaCell Therapeutics Corporation","startDate":"2024-05-29","conditions":"Breast Cancer, Breast Tumor, Cancer of Breast","enrollment":18},{"nctId":"NCT03066947","phase":"PHASE1, PHASE2","title":"SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer","status":"COMPLETED","sponsor":"BriaCell Therapeutics Corporation","startDate":"2017-05-05","conditions":"Breastcancer, Breast Neoplasm","enrollment":24}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Part of the Bria-IMT regimen"],"phase":"phase_3","status":"active","brandName":"SV-BR-1-GM","genericName":"SV-BR-1-GM","companyName":"BriaCell Therapeutics Corporation","companyId":"briacell-therapeutics-corporation","modality":"Biologic","firstApprovalDate":"","aiSummary":"SV-BR-1-GM is an autologous breast cancer immunotherapy that uses patient-derived dendritic cells loaded with breast cancer-associated antigens to stimulate anti-tumor immune responses. Used for Breast cancer (Phase 3 development).","enrichmentLevel":3,"visitCount":2,"trialStats":{"total":2,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}